3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Weight Loss
1
Pancreatic Neoplasms
1
Hematologic Neoplasms
1
Disease
1
Cachexia
1
Adenocarcinoma
1
Interventions
remune
1
olanzapine-fluoxetine combination
1
irinotecan sucrosofate
1
bermekimab
1
Surveys and Questionnaires
1
Ritonavir
1
Quality of Life
1
Olanzapine
1
Metformin
1
Fluoxetine
1
Fluorouracil
1
Exercise
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Weight Loss
×
bermekimab
×
Clear all
NCT03207724
2020-12-30
OnFX
Cedars-Sinai Medical Center
Phase 1
Completed
16 enrolled